ChinaDaily Briefs

Daily Brief China: JD Industrials, Dickson Concepts Intl, Meituan, Alibaba Health Information Technology, ZTO Express, PDD Holdings Inc, Xinhua Winshare, MicroPort Cardiac Rhythm Management, Horizon Construction Development and more

In today’s briefing:

  • JD Industrials Pre-IPO – Peer Comparison
  • Dickson Concepts 113 HK: Straight From The Ben Graham Stable, >40% Discount to NCAV
  • Meituan’s Recent Expansion in Hong Kong: A Review
  • Alibaba Health: Healthy 2H but Margins Have Very Little Room for Improvement (Quantamental)
  • Monthly Express Tracker | Prices Continue to Slide | Volume Pops | (May 2023)
  • Pinduoduo(PDD US): The Worst Is yet to Come
  • Xinhua Winshare (811 HK): We Love the Boredom
  • JD Industrials Pre-IPO – Peer Comparison – Some Interesting Nuggets from Peer Filings
  • Microport Cardiac Rhythm Management Pre-IPO Tearsheet
  • Horizon Construction Dev IPO Trading – Subscription Rates Still Weak, Despite Cornerstone Support

JD Industrials Pre-IPO – Peer Comparison

By Sumeet Singh

  • JD Industrials (JDI)  is looking to raise about US$1bn in its upcoming HK IPO. 
  • JDI is a leading industrial supply chain technology and service provider in China in terms of GMV in each year during the Track Record Period, according to CIC.
  • In this note, we will undertake a peer comparison versus domestic and international peers.

Dickson Concepts 113 HK: Straight From The Ben Graham Stable, >40% Discount to NCAV

By Sameer Taneja

  • Dickson Concepts Intl (113 HK), an HK distributor of luxury goods, is a classic example of a Graham net-net with a >40% discount to NCAV (Net Current Asset Value). 
  • The company has 4.7 bn HKD of cash against total liabilities of 2.3 bn HKD (on a market cap of 1.6 bn HKD), thus representing deep value. 
  • With an economic environment in HK for retail sales improving + an existing 8% dividend yield, we could make a case for higher dividend payments.

Meituan’s Recent Expansion in Hong Kong: A Review

By Shawn Yang

  • On May 22nd, Meituan launched its food delivery platform called KeeTa in Hong Kong SAR.
  • KeeTa’s expansion stratgies include Collaboration with branded chain merchants,lower ASP, subsidy campaign, and launching “On-time Guarantee”.
  • Sofar the initial results after launch seems to be in-line with expecation, while  there will still be a lot of challenges, like small market size and stabilized competition landscape.  

Alibaba Health: Healthy 2H but Margins Have Very Little Room for Improvement (Quantamental)

By Shifara Samsudeen, ACMA, CGMA

  • Alibaba Health Information Technology (241 HK) ’s 2HFY03/2023 revenues beat consensus by 1.4% while adjusted operating losses of RMB1.74m (0.01% of revenue) is significantly lower compared to 2HFY03/2022 and consensus.
  • Improvement in profitability was driven by improved GPM coupled with decrease in SG&A costs which helped offset increase in fulfilment costs as a result of the Covid-19 outbreak.
  • Our quantamental analysis suggests that Ali Health’s margins have very little room for improvement unless the company cuts down SG&A significantly while improving revenue % from non-direct pharmaceutical businesses.

Monthly Express Tracker | Prices Continue to Slide | Volume Pops | (May 2023)

By Daniel Hellberg

  • Industry and company reports show ASP declines gained momentum in April
  • April volume jumped 36% Y/Y on a weak comp from 2022 (Covid-19 lockdowns)
  • Our thesis: pricing is getting weaker, and this trend will soon impact margins

Pinduoduo(PDD US): The Worst Is yet to Come

By Eric Chen

  • The odds are high for PDD to miss consensus for 1Q results this Friday due to high base and deflating domestic growth drivers, despite TEMU’s momentum.
  • Among major China tech companies, PDD is likely to be the only one to register stagnant or even negative earnings growth for FY23, which has not been in the price.
  • A down cycle for PDD’s earnings growth leads us to assign 12x P/E to an estimated non-GAAP net profit of RMB39 billion for FY23, implying 15% downside. 

Xinhua Winshare (811 HK): We Love the Boredom

By Osbert Tang, CFA

  • Despite solid outperformance, share price of Xinhua Winshare (811 HK) is more than 100% covered by net cash of Rmb7.6bn. DPS has also risen uninterruptedly in the last 3 years. 
  • 1Q23 result demonstrated operating resilience as recurring profit soared 48.5%. Its franchise in textbook publication and distribution stayed well protected, securing profitability outlook.
  • We like XW’s boring businesses in the current depressed market. It trades on 4.5x PER with secured 6.6% dividend yield. The HA discount has widened to 10pp deeper than average. 

JD Industrials Pre-IPO – Peer Comparison – Some Interesting Nuggets from Peer Filings

By Sumeet Singh

  • JD Industrials is looking to raise about US$1bn in its upcoming HK IPO. 
  • JDI is a leading industrial supply chain technology and service provider in China in terms of GMV in each year during the Track Record Period, according to CIC.
  • We undertook a peer comparison in our previous note, in this note we talk about some additional useful information that we found interesting from peer filings.

Microport Cardiac Rhythm Management Pre-IPO Tearsheet

By Ethan Aw

  • MicroPort Cardiac Rhythm Management (1813053D CH) is looking to raise about US$200m in its upcoming HK IPO. The deal will be run by Goldman Sachs and CICC.
  • Microport Cardiac Rhythm Management (MCRM) is a R&D-driven, commercial-stage medical technology company specializing in active implantable medical devices for cardiac rhythm management (CRM). 
  • Its operations are dedicated to the design, development and commercialization of products and solutions to treat and manage arrhythmias and heart failure. 

Horizon Construction Dev IPO Trading – Subscription Rates Still Weak, Despite Cornerstone Support

By Ethan Aw

  • Horizon Construction Development (1887128D HK) raised around US$210m in its Hong Kong IPO.
  • HCD is an equipment operation service provider in China. It provides services covering the full cycle of projects.
  • In this note, we will talk about the trading dynamics and valuation.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars